Stockscreener 앱 받기
21.77
4.97%
1.03
전일 마감가:
$20.74
열려 있는:
$21.05
하루 거래량:
103.71K
Relative Volume:
0.35
시가총액:
$700.12M
수익:
$4.12M
순이익/손실:
$-56.68M
주가수익비율:
-3.9275
EPS:
-5.5429
순현금흐름:
$-51.44M
1주 성능:
+9.73%
1개월 성능:
+26.57%
6개월 성능:
-2.29%
1년 성능:
-22.19%
1일 변동 폭
$20.71
$22.49
1주일 범위
$19.73
$22.49
52주 변동 폭
$13.37
$32.27
Dianthus Therapeutics Inc Stock (DNTH) Company Profile
명칭
Dianthus Therapeutics Inc
전화
929-999-4055
주소
7 TIMES SQUARE, NEW YORK
DNTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DNTH
Dianthus Therapeutics Inc
|
21.77 | 612.33M | 4.12M | -56.68M | -51.44M | -5.5429 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.51 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.36 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.00 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
573.10 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.35 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Dianthus Therapeutics Inc Stock (DNTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-02 | 개시 | William Blair | Outperform |
| 2024-12-20 | 개시 | TD Cowen | Buy |
| 2024-10-03 | 개시 | Oppenheimer | Outperform |
| 2024-07-26 | 개시 | Robert W. Baird | Outperform |
| 2024-06-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-05-16 | 개시 | H.C. Wainwright | Buy |
| 2024-02-15 | 개시 | Stifel | Buy |
| 2023-12-26 | 개시 | Jefferies | Buy |
| 2023-11-22 | 개시 | Wedbush | Outperform |
| 2023-10-30 | 개시 | Guggenheim | Buy |
| 2023-09-28 | 개시 | Raymond James | Outperform |
| 2022-08-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-01-06 | 업그레이드 | Goldman | Neutral → Buy |
| 2021-08-20 | 재개 | Goldman | Neutral |
| 2021-08-03 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-22 | 재확인 | B. Riley Securities | Buy |
| 2021-06-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-05-18 | 개시 | B. Riley Securities | Buy |
| 2021-01-07 | 개시 | Mizuho | Buy |
| 2020-06-08 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-03-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2019-03-15 | 개시 | Raymond James | Outperform |
모두보기
Dianthus Therapeutics Inc 주식(DNTH)의 최신 뉴스
What drives Dianthus Therapeutics Inc. stock priceHigh-profit trading signals - jammulinksnews.com
Dianthus Therapeutics Inc. Stock Analysis and ForecastSuperior portfolio returns - jammulinksnews.com
What analysts say about Dianthus Therapeutics Inc. stockGame-changing returns - jammulinksnews.com
Is Dianthus Therapeutics Inc. a good long term investmentRapid wealth creation - jammulinksnews.com
Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Up 5.9%Should You Buy? - MarketBeat
Brokerages Set Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Target Price at $53.00 - MarketBeat
why dianthus therapeutics inc. stock attracts strong analyst attentionSafe and Smart Investment Picks - Newser
what makes dianthus therapeutics inc. stock price move sharplyVolume Spike Monitors - Newser
What makes Dianthus Therapeutics Inc. stock price move sharplyFree Deep Market Trend Analysis - Newser
How Dianthus Therapeutics Inc. stock performs during market volatilityFree Stock Selection - Newser
Why Dianthus Therapeutics Inc. stock attracts strong analyst attentionTriple Return With Stability - Newser
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Down 4.9%Should You Sell? - MarketBeat
Dianthus Therapeutics (NASDAQ:DNTH) Shares Up 8.4%Should You Buy? - MarketBeat
DNTH’s Stock Market Adventure: -16.38% YTD Growth Amidst Volatility - investchronicle.com
What is William Blair's Estimate for DNTH FY2025 Earnings? - MarketBeat
William Blair Begins Coverage on Dianthus Therapeutics (NASDAQ:DNTH) - MarketBeat
FY2025 Earnings Estimate for DNTH Issued By William Blair - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) Coverage Initiated at William Blair - Defense World
Dianthus Therapeutics stock rises after William Blair initiates coverage By Investing.com - Investing.com Canada
Dianthus Therapeutics Shares Climb After Analyst Coverage Boost - MSN
William Blair Initiates Dianthus Therapeutics at Outperform - MarketScreener
Dianthus Therapeutics (NASDAQ:DNTH) Shares Down 6%Time to Sell? - MarketBeat
Is Dianthus Therapeutics, Inc. overvalued or undervalued? - MarketsMojo
Dianthus Therapeutics Inc (DNTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.79%
0.12%
자본화:
|
볼륨(24시간):